The Galen Institute is delighted to announce that former presidential advisor Brian Blase is joining the Galen Institute as a Senior Fellow. Until last month, Brian served on the White House’s National Economic Council where he succeeded in implementing important health policy initiatives, including Health Reimbursement Arrangements, Short-Term Limited-Duration Health Plans, Association … [Read more...] about New Scholar Joins Galen Institute, Pens WSJ Piece!
Published on FORBES.com | The Trump administration finalized a new rule late today that offers important opportunities for businesses, especially small employers, to offer more health coverage options for their workers and for employees to have much more flexibility and control over their health care dollars. The rule undoes an Obama administration action that forbade workers … [Read more...] about New Administration Action Could Give 11 Million Workers More Health Insurance Options
Grace-Marie Turner testified on June 12 before the House Ways & Means Committee’s hearing on “Pathways to Universal Health Coverage.” She argued against dramatically expanding the role of government through Medicare for All or other new taxpayer-supported programs, such as Medicare Buy-In or a new “public option” insurer. She said we should instead target appropriate … [Read more...] about Grace-Marie Turner Testifies Before Congress About Universal Coverage
Published in The Los Angeles Times | PAEONIAN SPRINGS, Va. Conservatives and progressives agree that everyone should be able to get health insurance and have access to quality health care. But the divide over how to accomplish that goal is wide and deep. Progressives believe the government should make decisions about allocation of the resources in our health sector while conservatives … [Read more...] about Americans are in no mood for another health care upheaval
Last fall, I wrote in Forbes about U.S. based biotechnology manufacturer Amgen announcing it was slashing the list price of its breakthrough cholesterol-lowering drug Repatha by 60% in an effort to improve access and affordability for patients. Too many patients who had been prescribed the drug were walking away from the pharmacy empty handed because of sticker shock over … [Read more...] about A Closer Look At The Drug Rebate Proposal